Metropolitan Life Insurance Company (MetLife)’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $152K | Buy |
|
|||||
|
2023
Q3 | $84.5K | Buy |
|
|||||
|
2023
Q2 | $58.8K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $19.1K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $73.2K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $102K | Buy |
|
|||||
|
2020
Q4 | $60.9K | Sell |
|
|||||
|
2020
Q3 | $108K | Sell |
|
|||||
|
2020
Q2 | $84K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $105K | Buy |
|
|||||
|
2019
Q2 | $142K | Hold |
|
|||||
|
2019
Q1 | $264K | Hold |
|
|||||
|
2018
Q4 | $157K | Hold |
|
|||||
|
2018
Q3 | $220K | Hold |
|
|||||
|
2018
Q2 | $267K | Buy |
|